Feedback (FDBK) – Re Media Articles
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to update shareholders following the recent media articles regarding the use of multi-parametric MRI scans for the diagnosis of prostate cancer. It was widely reported in the national press and on the BBC website on 20 January 2017 that a trial led by Mr […]
Feedback (FDBK): Above 50 day line points as high as 5p – Master Investor
by Zak Mir It appeared that for a while there was a degree of negative sentiment associated with medical imaging group Feedback (LON:FDBK), but the background noise now looks to have finally cleared, so to speak. It can be seen from the daily chart of Feedback that we are finally back on the front foot, […]
Dr Balaji Ganeshan speaks at International Conference on Artificial Intelligence in Healthcare – Feedback plc (FDBK)
Feedback (FDBK) – Dr Balaji Ganeshan speaks at International Conference on Artificial Intelligence in Healthcare. The conference is at the School of Pharmacy & Technology Management at NMIMS (www.nmims.edu) Shirpur Campus, India. More on the key speakers <a href="https://aihc.nmims this article.edu/key-speakers.php”>here The Conference provides an interdisciplinary forum for research developers to present and discuss […]
Malcolm Stacey, ShareProphets – Tom no likey this medical pioneer. But I do…
Hello Share Rattlers. Quite a few of my friends face a grim Christmas. They are undergoing radio and chemo treatment for cancer. Is it me, or is the number of cases growing even faster than normal? I am invested in a few companies that are fighting this scourge. One such outfit is Feedback (FDBK). This […]
Texture Analysis on Computed Tomography Predicts the Outcome of Patients with Hodgkin Lymphoma – Feedback Plc (FDBK)
Background Texture analysis is a novel approach, which analyses the distribution of pixel on computed tomography (CT) within a region of interest. CT-based texture analysis (CTTA) can be applied to images that are acquired in routine clinical practice and provide prognostic information in patients with non-small cell lung cancer or colorectal adenocarcinoma. We aimed to […]
Feedback Plc (FDBK) – Total Voting Rights
Feedback plc (AIM: FDBK), the medical imaging software company, announces that the issued share capital of the Company at the date of this announcement comprises 218,793,857 ordinary shares with one voting right each. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required […]
Daily Mail – SMALL CAP IDEAS: Feedback’s new chairman reveals pioneering cancer imaging program is proving a hit
From Daily Mail by Ian Lyall at Proactive Investors for ThisIsMoney Dr Alastair Riddell’s CV reveals a high-flying career with the forerunners of what are now GE Healthcare, Johnson & Johnson and Pfizer, followed by spells guiding businesses to IPO or trade sale. So, what attracted him to the challenge of Feedback, the Cambridge-based AIM-listed […]
TexRAD presenting 19 papers at RSNA 2016 – Feedback (FDBK)
TexRAD is attending the 102nd scientific assembly and annual meeting of the Radiological Society of North America, running from the 27th November to 2nd December 2016 at the McCormick Place in Chicago, USA. This year at the RSNA there will be around 19 presentations (5 of which have won student awards) from our customer sites spread across USA, […]
Feedback Plc (FDBK) – Director shareholding
Feedback Plc (FDBK) – Director / PDMR Shareholding Feedback plc (AIM: FDBK), the medical imaging software company, announced on 1 June 2016, upon the appointment of Dr Alastair Riddell as Non-Executive Chairman of the Company, that Tom Charlton, Non-Executive Deputy Chairman of the Company, had made a conditional gift of 5,000,000 ordinary shares of 0.25 pence […]
Feedback Plc (FDBK) – Issue of Equity & Director – PDMR shareholding
Feedback Plc (FDBK) – Issue of Equity & Director / PDMR Shareholding Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to announce that it has exercised its discretionary right to issue 15,120,000 new ordinary shares of 0.25 pence each at a deemed issue price of 1.25p to Tom Charlton, non-executive deputy chairman of […]